Afrezza: Rapid-Acting Inhaled Insulin Approved for Children ≥ 6 Years Old with Diabetes Prepared on behalf of PES Drugs and Therapeutics Committee by Pranav Gupta, MD and edited…
New Meds and Tech from the D&T Committee: Teplizumab Approval Expanded to Stage 3 Type 1 Diabetes (Ages 8-17) Prepared on behalf of PES Drugs and Therapeutics Committee by…
New Meds and tech from D&T Committee: IMCIVREE® (setmelanotide) injection Prepared by Daniel Mak, MD; Edited by Neha Patel, DO On March 19, 2026, the FDA approved and…
Teplizumab Approval Expanded to Children >1 Year with Stage 2 Type 1 Diabetes (T1D) Prepared on behalf of PES Drugs and Therapeutics Committee by Pranav Gupta, MD…
New Drugs and Therapeutics Update: JUXTAPID® (lomitapide) capsules Prepared by Daniel Mak, MD On March 3rd, 2026, the FDA approved and expanded indication for JUXTAPID (lomitapide) capsules for…
New Drugs and Therapeutics Update: Sogroya® (somapacitan-beco) Injection Prepared by Daniel Mak, MD; Edited by Neha Patel, DO On February 27th, 2026, the FDA approved Sogroya®…
Depo-Provera® and Increased Risk of Meningioma: FDA-Label Update Written by: Anna Ryabets-Lienhard, DO as part of Drugs and Therapeutics Committee In December 2025, the U.S. Food and…
Navepegritide (Yuviwel®) for Children with Achondroplasia: New Drugs and Therapeutics Written by Anna Ryabets-Lienhard, DO Edited by Neha Patel, DO and Emily Breidbart, MD On February…
New Drugs and Therapeutics Update: DESMODA™ (desmopressin acetate) Oral Solution Prepared by Daniel Mak, MD DESMODA® (desmopressin acetate) Oral Solution On February 25th, 2026, the FDA…
Mounjaro (tirzepatide) approved in Pediatrics Prepared on behalf of PES Drugs and Therapeutics Committee by, Evan Graber, DO, Emily Breidbart, MD, and Neha Patel, DO. Based on…